ERBB2 and breast cancer: In both the TCGA, METABRIC and Oslo2 datasets, the mean signature score was highest in basal-like/TNBC and normal-type breast cancer, followed by the Luminal A subtype and with HER2 and Luminal B subtypes exhibiting lower signature scores (Fig. 5D).